Covid-19: Tamil Nadu vaccinates 7,91,889 people during 21st mega camp

The Tamil Nadu public health department in a statement on Sunday said that the state vaccinated 7,91,889 people during the 21st mega vaccination camp held across the state on Saturday.

Topics
Coronavirus Vaccine | Tamil Nadu | Coronavirus

IANS  |  Chennai 

Chennai
A health worker administers a dose of the Covid-19 vaccine to a person at a drive-in vaccination centre, at MGM Hospital, in Chennai (Photo: PTI)

The public health department in a statement on Sunday said that the state vaccinated 7,91,889 people during the 21st mega vaccination camp held across the state on Saturday. The state has been conducting mega vaccination camps since September 12, 2021.

Of the 7,91,889 people who were inoculated on Saturday, 1,86,785 received the first dose of their vaccine while 5,77,397 people took the second dose. A total 27,707 people received the booster dose or precaution dose during the mega vaccine camp on Saturday.

The state health department in the statement also said that there will not be any mega vaccination on Sunday.

Health Minister, Ma Subramanian while speaking to IANS said, "After the 21st mega vaccination camp, the vaccination rate stood at 90.78 per cent for the first dose and 70.02 per cent for the second dose respectively."

He also said that five per cent of the children in the age group of 15-18 were given the second dose of the vaccine in the past four days. 0The state, according to the health minister has already inoculated 26,61,866 children in the age group of 15-18 with the first dose of the vaccine. This accounts for almost 80 per cent of the eligible population in the age group of 15-18.

Subramanian also said that reopening of schools will increase the pace of vaccination of children in the age group of 15-18.

--IANS

aal/skp/

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus Vaccine
First Published: Sun, February 06 2022. 15:54 IST
RECOMMENDED FOR YOU